CD33 and myelodysplastic syndrome: In the myeloid space, the anti-CD3/CD33 Duobody JNJ-67571244 is in phase 1 testing for r/r acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS) (NCT03915379) [93,94].